The objectives of this project ar:1) to assess the practical effects of variations in 3 dietary factors (Fe, Ca, citrate) on Al retention; 2) to determine the importance of age, duration of A1 exposure & renal function on A1 metabolism & to assess the extent to which these physiological factors modify interactions of the dietary factors with A1; & 3) to develop a more sensitive model for studying A1 metabolism. In the first series of studies (1,1a,1b) we will develop a """"""""desferoxamine test"""""""" & determine whether the changes in serum A1 in response to an infusion of desferoxamine can be used to monitor the total body load or an exchangeable pool of A1. Then the response of rats (tissue A1, response to desferoxamine test, urine A1) to chronic ingestion & to repeated injection of 5 different levels of A1 will be compared. In the second series of studies (2,2a,3,3a) renal function of rats will be reduced by surgery to approximate the impairment that might occur with aging. We will monitor kidney function, absorption and tissue levels of A1, Ca, Mg & Fe & the t1/2 of A1 in tissues. In Study 4 duration of exposure to dietary A1 (2 mo or 1 year) and age of rats (approximately 9 mo or 21 mo) on absorption, urinary excretion & tissue levels of A1, Ca, Mg & Fe on t1/2 of A1 in tissues will be determined. The relative importance of changes in kidney function and bone resorption ion A1 retention in these aging rats will be assessed statistically. In the last series of studies (5,5a,5b,6,6a,7) the effects of variations in intake of Fe, Ca & citrate on absorption, urinary excretion & tissue levels of A1, Fe & Ca and on t1/2 of A1 tissues will be assessed using animal models that we've developed in previous studies to maximize sensitivity. We will also evaluate the use of Ga-67 as a marker for A1 in a variety of situations. In the assessment of effects of dietary Ca on A1 retention, we will evaluate the effect of confounding factors such as poor growth and reduced food intake when calcium intake is very low and nephrocalcinosis when calcium intake is high.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK041116-01A1
Application #
3241749
Study Section
Nutrition Study Section (NTN)
Project Start
1990-05-01
Project End
1993-04-30
Budget Start
1990-05-01
Budget End
1991-04-30
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Earth Sciences/Natur
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Sutherland, J E; Radzanowski, G M; Greger, J L (1996) Bile is an important route of elimination of ingested aluminum by conscious male Sprague-Dawley rats. Toxicology 109:101-9
Greger, J L; Radzanowski, G M (1995) Tissue aluminium distribution in growing, mature and ageing rats: relationship to changes in gut, kidney and bone metabolism. Food Chem Toxicol 33:867-75
Greger, J L; Chang, M M; Radzanowski, G M (1995) Comparison of tissue retention of aluminum and Ga-67: effects of iron status in rats. Toxicology 100:1-9
Ecelbarger, C A; MacNeil, G G; Greger, J L (1994) Aluminum retention by aged rats fed aluminum and treated with desferrioxamine. Toxicol Lett 73:249-57
Greger, J L (1993) Aluminum metabolism. Annu Rev Nutr 13:43-63
Greger, J L (1992) Dietary and other sources of aluminium intake. Ciba Found Symp 169:26-35;discussion 35-49
Greger, J L; Powers, C F (1992) Assessment of exposure to parenteral and oral aluminum with and without citrate using a desferrioxamine test in rats. Toxicology 76:119-32
Greger, J L (1992) Using animals to assess bioavailability of minerals: implications for human nutrition. J Nutr 122:2047-52
Ecelbarger, C A; Greger, J L (1991) Dietary citrate and kidney function affect aluminum, zinc and iron utilization in rats. J Nutr 121:1755-62